SEALAND - An ALLG phase 3 randomised trial of Selinexor and Lenalidomide versus lenalidomide maintenance post Autologous stem cell transplant for patients with Newly Diagnosed multiple myeloma

Project: Research

Project Details

StatusActive
Effective start/end date25/05/21 → 24/05/26

Keywords

  • phase 3 study
  • treatment safety
  • treatment efficacy
  • Myeloma